Alivus Life Sciences standalone net profit rises 51.31% in the September 2026 quarter

Sales rise 15.99% to Rs 681.99 crore

Net profit of Alivus Life Sciences rose 51.31% to Rs 196.75 crore in the quarter ended September 2026 as against Rs 130.03 crore during the previous quarter ended September 2025. Sales rose 15.99% to Rs 681.99 crore in the quarter ended September 2026 as against Rs 587.98 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	681.99	587.98	16
OPM %	38.88	30.47	-
PBDT	283.80	192.58	47
PBT	261.98	174.14	50
NP	196.75	130.03	51

Powered by Capital Market - Live News